Poster Session 2
Sarah T. Mehl, MD (she/her/hers)
MFM Fellow
McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Abigail S. Zamorano, MD
Assistant Professor
Division of Gynecology Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas Health Science Center in Houston, McGovern Medical School
Houston, Texas, United States
Beatrice Valentini, MD
Resident
University of Parma
University of Parma, Emilia-Romagna, Italy
Joe Haydamous, MD (he/him/his)
Research Assistant 3
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Neha Agarwal, MBBS, MD
Post doctoral Research Fellow
Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, UTHealth McGovern Medical School, Houston, TX, USA
Houston, Texas, United States
Han-Yang M. Chen, PhD
Associate Professor
McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Edgar A. Hernandez-Andrade, MD, PhD (he/him/his)
Professor
McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Sean C. Blackwell, MD
Professor and Chair
McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Baha M. Sibai, MD
Professor
McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Farah H. Amro, MD
Assistant Professor
McGovern Medical School at UTHealth Houston
Bellaire , TX, United States
Risk factors for placenta accreta spectrum (PAS) other than prior cesarean delivery (CD) and placenta previa remain unclear. In those with placenta previa, there is limited data regarding the role of dilation and curettage (D&C) and risk of PAS. We examined whether an association between D&C and PAS in pregnancies with placenta previa exists.
Study Design:
Retrospective cohort study of pregnancies with finding of placenta previa on third trimester ultrasound from 2016 – 2024 and delivery within our hospital system. Pregnancies were divided into group 1: CD≤1 and group 2: CD≥2, and then subclassified according to history of D&C. PAS was diagnosed based on pathology findings. Logistic regression was performed to calculate adjusted relative risk for PAS controlling for gestational age at delivery.
Results:
A total of 274 pregnancies with third trimester placenta previa and delivery outcomes at our hospital were reviewed. Characteristics including maternal age, parity, BMI, and IVF were similar within groups (Table 1). The rate of PAS was not different among those with and without D&C in group 1 (26% versus 15%, p=0.4) or group 2 (74% versus 67%, p=0.2). Delivery at < 36 weeks was more frequent in those with D&C among group 1 (69% versus 47%, p=0.016), and not different in group 2 (89% vs 83%, p=0.73). Figure 1 demonstrates PAS pathology in both groups according to history of D&C. In this cohort of pregnancies with placenta previa, rate of PAS was not changed based on history of D&C. We did note an association with increased placental invasion with history of D&C, although not statistically significant. Interestingly in those with prior CD≤1 and history of D&C, preterm delivery < 36 weeks was 1.5 times more likely than in those without history of D&C. A large trial is needed to evaluate the role of D&C with incidence of PAS and preterm labor.
Conclusion: